Patents by Inventor Robert B. Skinner, Jr.

Robert B. Skinner, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Characterization of microbial deposition and immune response at the basement membrane and methods relating thereto
    Patent number: 9746478
    Abstract: Methods for diagnosing a systemic or autoimmune disorder and methods for treating the same by inducing the production of or otherwise providing an autoantibody that recognizes a skin basement membrane component.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: August 29, 2017
    Inventors: E. William Rosenberg, Patricia W. Noah, Robert B. Skinner, Jr., Timothy D. Mandrell, Jagat Narula, Charles R. Handorf
  • Composition and method for treating soft nails
    Patent number: 6986884
    Abstract: A composition and method for treating soft nails, particularly soft fingernails, the composition including bisphosphonate, preferably alendronate sodium, in a vehicle effective for topical administration.
    Type: Grant
    Filed: September 4, 2002
    Date of Patent: January 17, 2006
    Inventors: E. William Rosenberg, Robert B. Skinner, Jr.
  • Composition and method for treatment of psoriasis
    Patent number: 5990100
    Abstract: Pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti-psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: November 23, 1999
    Assignees: Panda Pharmaceuticals, L.L.C., The University of Tennessee Research Corporation
    Inventors: E. William Rosenberg, Thomas M. Glenn, Robert B. Skinner, Jr., Patricia W. Noah
  • Composition and method for treatment of psoriasis
    Patent number: 5886038
    Abstract: A pharmaceutical composition for use in the treatment of psoriasis, having isopropyl myristate as its only active ingredient.
    Type: Grant
    Filed: March 24, 1998
    Date of Patent: March 23, 1999
    Assignees: Panda Pharmaceuticals, L.L.C., The University of Tennessee Research Corporation
    Inventors: Thomas M. Glenn, E. William Rosenberg, Robert B. Skinner, Jr., Patricia W. Noah